当前位置:首页 - 行情中心 - 天目药业(600671) - 财务分析 - 现金流量表

天目药业

(600671)

  

流通市值:20.83亿  总市值:20.84亿
流通股本:1.22亿   总股本:1.22亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金137,811,585.19108,552,386.9143,618,766.57198,056,474.86
  收到的税费返还25,081.09153.82153.8240,083.95
  收到其他与经营活动有关的现金16,321,184.8212,709,875.1212,039,746.681,358,039.02
  经营活动现金流入小计154,157,851.1121,262,415.8555,658,667.07199,454,597.83
  购买商品、接受劳务支付的现金105,825,661.3371,649,239.0442,273,319.41144,270,195.07
  支付给职工以及为职工支付的现金31,625,825.820,757,435.2110,073,211.1739,406,266.51
  支付的各项税费22,524,848.4118,285,829.185,857,360.6413,762,920.5
  支付其他与经营活动有关的现金25,012,604.3621,442,006.697,107,081.9238,689,661.35
  经营活动现金流出小计184,988,939.9132,134,510.1265,310,973.14236,129,043.43
  经营活动产生的现金流量净额-30,831,088.8-10,872,094.27-9,652,306.07-36,674,445.6
二、投资活动产生的现金流量:
  取得投资收益收到的现金3,993.353,993.35--
  处置固定资产、无形资产和其他长期资产收回的现金净额22,7685,1545,15430
  收到的其他与投资活动有关的现金3,500,0013,500,0011-
  投资活动现金流入小计3,526,762.353,509,148.355,15530
  购建固定资产、无形资产和其他长期资产支付的现金26,663,454.6619,607,620.514,659,236.120,553,214.31
  取得子公司及其他营业单位支付的现金---6,307,890.44
  支付其他与投资活动有关的现金3,500,0013,500,0013,500,001-
  投资活动现金流出小计30,163,455.6623,107,621.518,159,237.126,861,104.75
  投资活动产生的现金流量净额-26,636,693.31-19,598,473.16-8,154,082.1-26,861,074.75
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,770,0001,770,00030,0007,432,400
  其中:子公司吸收少数股东投资收到的现金1,770,0001,770,00030,000-
  取得借款收到的现金118,752,80090,023,00059,396,800149,708,140
  收到其他与筹资活动有关的现金---83,464,100.32
  筹资活动现金流入小计120,522,80091,793,00059,426,800240,604,640.32
  偿还债务支付的现金89,280,00084,280,00061,280,000125,450,000
  分配股利、利润或偿付利息支付的现金4,725,879.463,037,813.281,478,893.948,583,889.68
  支付其他与筹资活动有关的现金10,414,637.857,104,385.672,070,48093,533,851.24
  筹资活动现金流出小计104,420,517.3194,422,198.9564,829,373.94227,567,740.92
  筹资活动产生的现金流量净额16,102,282.69-2,629,198.95-5,402,573.9413,036,899.4
五、现金及现金等价物净增加额-41,365,499.42-33,099,766.38-23,208,962.11-50,498,620.95
  加:期初现金及现金等价物余额47,463,991.4747,463,991.4747,463,991.4997,962,612.42
  期末现金及现金等价物余额6,098,492.0514,364,225.0924,255,029.3847,463,991.47
补充资料:
  净利润-6,397,830.43-21,865,054.77
  资产减值准备-494,501.47-2,470,893.55
  固定资产和投资性房地产折旧-7,123,374.13-11,694,757.57
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-7,123,374.13-11,694,757.57
  无形资产摊销-79,408.38-154,791.6
  长期待摊费用摊销-3,680,851.67-3,467,470.09
  处置固定资产、无形资产和其他长期资产的损失-6,675.6-4,452.7
  固定资产报废损失-653,041.9-250,845.86
  财务费用-3,257,961.5-5,560,910.1
  投资损失--3,993.35--28,842.06
  递延所得税--538,581.88--444,522.33
  其中:递延所得税资产减少-1,177,876.84--3,622,512.55
    递延所得税负债增加--1,716,458.72-3,177,990.22
  存货的减少-6,524,613.73--9,376,648.4
  经营性应收项目的减少--19,370,557.87--64,075,418.6
  经营性应付项目的增加--22,856,306.36--16,420,681.46
  融资租入固定资产-2,117,115.15-20,051,344.32
  现金的期末余额-14,364,225.09-47,463,991.47
  减:现金的期初余额-47,463,991.47-97,962,612.42
  现金及现金等价物的净增加额--33,099,766.38--50,498,620.95
公告日期2025-10-292025-08-282025-04-282025-04-01
审计意见(境内)标准无保留意见
TOP↑